Skip Navigation

Back to Index

Teva Authorized Generic Provides Cheaper Option for Asthma Treatment

Teva Pharmaceutical Industries, Ltd. simultaneously launched their:

  • AirDuoTM RespiClick® (fluticasone propionate and salmeterol inhalation powder)
  • Authorized generic for the treatment of asthma in patients 12 years and older.1

Teva’s product competes with GlaxoSmithKline’s Advair Diskus® (fluticasone propionate and salmeterol), approved for the treatment of asthma in patients four years and older.2

Teva’s authorized generic product provides a lower-cost alternative to Advair Diskus. The fluticasone/salmeterol product contains the same active ingredients as Advair Diskus, but with a lower price point.3 Additionallly, Teva products exhibit parity pricing, meaning prices do not increase with strength.

This chart shows the average wholesale price (AWP) per device:

Drug Name

Low Dose

Intermediate Dose

High Dose

Authorized generic fluticasone propionate/salmeterol Teva product

$110

$110

$110

Advair Diskus®

$350

$430

$570

Branded AirDuoTM RespiClick®

$340

$340

$340

                          

On a Blue Cross and Blue Shield of North Carolina (Blue Cross NC) formulary, the Teva AirDuoTM authorized generic is placed on a lower cost-share tier, and may have a lower out-of-pocket cost for members with deductibles:

Drug Name

Four-Tier Formulary

Authorized generic fluticasone propionate/salmeterol Teva product

Tier 1

Advair Diskus®

Tier 2

Branded AirDuoTM RespiClick®

 Tier 3

 

What can providers do to help members lower their cost share and improve adherence to asthma treatment?

  • In patients 12 years and older, please consider prescribing the authorized generic fluticasone propionate/salmeterol.
  • The authorized generic cannot be substituted for brand AirDuoTM at the pharmacy. Therefore, you must write fluticasone/salmeterol for the specific strength.
    Example – fluticasone/salmeterol 55/14mcg, one inhalation twice daily

  1. AirDuo RespiClick (fluticasone propionate/salmeterol). FDA. Accessed Aug 2017 at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208799Orig1s000TOC.cfm
  2. Advair Diskus (fluticasone propionate and salmeterol inhalation powder), for oral inhalation [prescribing information]. Research Triangle Park, NC. Revised Feb 2017. Accessed Aug 2017 at: https://www.gsksource.com/advair_diskus
  3. Price comparison based on Average Wholesale Price (AWP)
  4. Teva launches AirDuo RespiClick and its authorized generic, two inhalers containing fluticasone propionate and salmeterol. Teva Pharmaceutical Industries Ltd. Accessed Aug 2017 at: http://www.tevapharm.com/news/teva_launches_airduo_respiclick_and_its_authorized_generic_two_inhalers_containing_fluticasone_propionate_and_salmeterol_04_17.aspx